We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.8M
2
ELV icon
Elevance Health
ELV
+$34.6M
3
AET
Aetna Inc
AET
+$33.5M
4
WBA
Walgreens Boots Alliance
WBA
+$32.4M
5
AME icon
Ametek
AME
+$29.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
26
DELISTED
Alexion Pharmaceuticals
ALXN
$56.4M 0.9%
461,150
+439,900
+2,070% +$53.8M
AON icon
27
Aon
AON
$77.3B
$53.8M 0.86%
482,304
+172,406
+56% +$19.2M
UNH icon
28
UnitedHealth
UNH
$382B
$49.1M 0.78%
306,500
+74,500
+32% +$11.1M
ABT icon
29
Abbott
ABT
$180B
$48.4M 0.77%
1,260,000
+240,000
+24% +$9.52M
BABA icon
30
Alibaba
BABA
$269B
$46.8M 0.75%
532,980
-54,844
-9% -$5.28M
CELG
31
DELISTED
Celgene Corp
CELG
$46.5M 0.74%
402,000
+56,500
+16% +$6.29M
LVNTA
32
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$46.4M 0.74%
1,258,983
-517,755
-29% -$20.3M
INCY icon
33
Incyte
INCY
$23.5B
$44.9M 0.72%
447,500
+149,000
+50% +$14.5M
SPGI icon
34
S&P Global
SPGI
$126B
$44.6M 0.71%
414,512
-58,597
-12% -$7M
Y
35
DELISTED
Alleghany Corp
Y
$42.7M 0.68%
70,250
+12,000
+21% +$6.69M
AMD icon
36
Advanced Micro Devices
AMD
$851B
$42.7M 0.68%
3,764,668
+986,248
+35% +$8.27M
MU icon
37
Micron Technology
MU
$1.04T
$42.2M 0.67%
1,926,040
+71,306
+4% +$1.34M
SPLK
38
DELISTED
Splunk Inc
SPLK
$41.5M 0.66%
811,703
+28,045
+4% +$1.61M
ACN icon
39
Accenture
ACN
$89.9B
$39.6M 0.63%
337,795
– –
MRK icon
40
Merck
MRK
$324B
$39.2M 0.63%
697,113
-636,991
-48% -$37.3M
BAX icon
41
Baxter International
BAX
$11.6B
$38.8M 0.62%
875,000
+275,000
+46% +$12.7M
BAH icon
42
Booz Allen Hamilton
BAH
$8.7B
$37.4M 0.6%
1,035,651
-774,612
-43% -$26.3M
AMAT icon
43
Applied Materials
AMAT
$426B
$36.7M 0.59%
1,138,193
+185,843
+20% +$5.65M
BAC icon
44
Bank of America
BAC
$435B
$36.1M 0.58%
1,633,306
+56,578
+4% +$1.09M
MDT icon
45
Medtronic
MDT
$107B
$35.6M 0.57%
499,733
-283,982
-36% -$22.3M
ICLR icon
46
Icon
ICLR
$12.8B
$35M 0.56%
465,217
-154,676
-25% -$12M
AET
47
DELISTED
Aetna Inc
AET
$34.7M 0.55%
+279,500
New +$33.5M
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$11.5B
$34.3M 0.55%
414,500
+145,000
+54% +$12.5M
WBA
49
DELISTED
Walgreens Boots Alliance
WBA
$34.1M 0.54%
412,000
+392,000
+1,960% +$32.4M
BSX icon
50
Boston Scientific
BSX
$65.8B
$33.9M 0.54%
1,565,000
+725,000
+86% +$15.8M
1
2
3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.